Optum: Why COVID-19 could significantly change the drug development pipeline,

Clinical trials did experience some delays, the report notes, with one study tracking 2,500 trials planned for 2020 and finding 65% experienced a delay …, Clinical trials did experience some delays, the report notes, with one study tracking 2,500 trials planned for 2020 and finding 65% experienced a delay …, Read More

Scroll to Top